Julie R Ingelfinger Selected Research

Insulin (Novolin)

4/2020	Comparison of the effects of insulin and SGLT2 inhibitor on the Renal Renin-Angiotensin system in type 1 diabetes mice.
1/2019	Hedgehog Interacting Protein (Hhip) Regulates Insulin Secretion in Mice Fed High Fat Diets.
1/2017	Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice.
12/2002	Insulin inhibits dexamethasone effect on angiotensinogen gene expression and induction of hypertrophy in rat kidney proximal tubular cells in high glucose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie R Ingelfinger Research Topics

Disease

21	Hypertension (High Blood Pressure) 01/2023 - 01/2002
11	Fibrosis (Cirrhosis) 01/2021 - 02/2008
9	Hypertrophy 09/2023 - 02/2002
7	Albuminuria 04/2020 - 02/2008
7	Kidney Diseases (Kidney Disease) 04/2016 - 01/2009
7	Hypoxia (Hypoxemia) 04/2009 - 09/2003
6	Diabetic Nephropathies (Diabetic Nephropathy) 09/2023 - 05/2006
6	Hyperglycemia 01/2021 - 12/2002
6	Chronic Renal Insufficiency 01/2021 - 05/2006
5	Type 2 Diabetes Mellitus (MODY) 10/2023 - 06/2008
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 10/2015
3	Renal Hypertension 01/2018 - 10/2012
3	Ischemia 04/2009 - 03/2002
3	Reperfusion Injury 04/2009 - 05/2002
3	Acute Kidney Injury (Acute Renal Failure) 06/2005 - 01/2003
2	Glucose Intolerance 01/2019 - 10/2006
2	Hemolytic-Uremic Syndrome 06/2013 - 02/2008
1	Poisoning 01/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Segmental glomerulosclerosis 01/2022
1	Overweight 01/2021
1	Stroke (Strokes) 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021
1	Obesity 01/2021
1	Hyperaldosteronism (Conn Syndrome) 12/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Insulin Resistance 01/2020
1	Glycosuria 10/2019
1	Pancreatitis 01/2019
1	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2017
1	Congenital Abnormalities (Deformity) 11/2017
1	Disease Progression 10/2017
1	Weight Gain 03/2016
1	Isolated Systolic Hypertension 05/2015
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 06/2014
1	Inflammation (Inflammations) 05/2012

Drug/Important Bio-Agent (IBA)

15	AngiotensinogenIBA 09/2023 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
8	AlbuminsIBA 09/2023 - 03/2008
7	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 02/2002
7	Blood Glucose (Blood Sugar)IBA 09/2023 - 02/2008
7	CreatinineIBA 09/2023 - 05/2015
5	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 10/2019 - 10/2012
5	AngiotensinsIBA 01/2018 - 06/2010
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 02/2008
5	CatalaseIBA 10/2014 - 02/2008
4	Insulin (Novolin)FDA Link 04/2020 - 12/2002
4	Heterogeneous-Nuclear Ribonucleoprotein Group F-HIBA 01/2017 - 10/2012
3	SaltsIBA 01/2024 - 06/2012
3	Angiotensin IIIBA 01/2022 - 05/2004
3	Messenger RNA (mRNA)IBA 01/2021 - 02/2002
3	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2020 - 01/2019
3	Streptozocin (Streptozotocin)FDA Link 01/2018 - 05/2006
3	Hydralazine (Apresoline)FDA LinkGeneric 07/2016 - 02/2008
3	Collagen Type IV (Type IV Collagen)IBA 03/2016 - 02/2008
3	Cyclin-Dependent Kinase Inhibitor p27IBA 10/2003 - 02/2002
2	LipidsIBA 09/2023 - 03/2016
2	Sodium-Glucose Transport ProteinsIBA 01/2023 - 11/2015
2	CanagliflozinIBA 04/2020 - 10/2019
2	angiotensin I (1-7)IBA 01/2018 - 05/2015
2	Perindopril FDA LinkGeneric 07/2016 - 01/2009
2	Angiotensin-Converting Enzyme 2IBA 05/2015 - 01/2009
2	EnzymesIBA 06/2013 - 03/2008
2	Caspase 3 (Caspase-3)IBA 01/2009 - 02/2008
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2009 - 02/2002
2	LuciferasesIBA 03/2008 - 05/2006
2	ElementsIBA 03/2008 - 05/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2008 - 05/2006
2	Shiga Toxin (Shigella Toxin)IBA 02/2008 - 06/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2005 - 01/2003
2	Type 1 Angiotensin ReceptorIBA 05/2004 - 01/2002
2	salicylhydroxamic acid (SHAM)IBA 05/2002 - 03/2002
1	Fatty Acid-Binding ProteinsIBA 09/2023
1	Scavenger Receptors (Scavenger Receptor)IBA 09/2023
1	SodiumIBA 09/2023
1	Sodium-Glucose Transporter 2IBA 01/2023
1	AldosteroneIBA 01/2023
1	ReninIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	semaglutideIBA 01/2021
1	finerenoneIBA 12/2020
1	NADPH Oxidase 4IBA 01/2018
1	Tolvaptan FDA Link 11/2017
1	Type 2 Angiotensin ReceptorIBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2017
1	Aquaporin 1IBA 07/2016
1	Losartan (Cozaar)FDA LinkGeneric 07/2016
1	7-Ala-angiotensin (1-7)IBA 06/2013
1	AntioxidantsIBA 06/2013
1	Thromboplastin (Tissue Factor)IBA 06/2013
1	InterferonsIBA 05/2012

Therapy/Procedure

6	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2016 - 01/2016
5	Transplantation 04/2016 - 01/2016
4	Therapeutics 10/2023 - 04/2002
2	Renal Dialysis (Hemodialysis) 11/2003 - 01/2003
1	Glycemic Control 04/2020
1	Bariatric Surgery 01/2020
1	Antibiotic Prophylaxis 06/2014